Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ChemoSen3D
AddedFeb 18, 2024
UpdatedJun 18, 2026
ChemoSen3D

ChemoSen3D

Seed

ChemoSen3D rapidly develops personalized medicine clinical assays using 3D bioprinting technology.

HQ
Houston, TX, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize cancer treatment, ChemoSen3D leverages 3D bioprinting technology to rapidly develop personalized medicine clinical assays. The company focuses on creating advanced clinical diagnostics that enable physicians to select the most effective drugs for cancer patients at the point of care. By integrating biotechnology and 3D cell culture, ChemoSen3D aims to enhance the precision and speed of cancer treatment decisions.

ChemoSen3D has garnered attention from notable figures in the biotechnology and healthcare sectors, attracting significant investment to fuel its innovative approach. The company's key achievements include the successful development of several rapid clinical assays that have shown promise in improving patient outcomes. Through its pioneering work, ChemoSen3D is making a substantial impact on personalized medicine, offering new hope for more effective cancer treatments.

ChemoSen3D - Similar Companies

Systemic Bio logo

Systemic Bio

systemic.bio

BioSapien logo

BioSapien

biosapien.com

SEngine Precision Medicine logo

SEngine Precision Medicine

3D Biotek logo

3D Biotek

3dbiotek.com

Known Medicine logo

Known Medicine

Viscient Bio logo

Viscient Bio

3DBio logo

3DBio

3dbiocorp.com

VivoSim Labs logo

VivoSim Labs

organovo.com

Nano3D Biosciences logo

Nano3D Biosciences

n3dbio.com

Advanced Chemotherapy Technologies logo

Advanced Chemotherapy Technologies

Empiri logo

Empiri

empiricancer.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

FluidForm logo

FluidForm

fluidformbio.com

Zpredicta logo

Zpredicta

Cypre logo

Cypre

cypre.co

ChemoSen3D - Quick Facts

Who are ChemoSen3D's competitors?

Companies similar to ChemoSen3D include Systemic Bio, BioSapien, SEngine Precision Medicine and 3D Biotek.

When was ChemoSen3D founded?

ChemoSen3D was founded in 2018.

Where is ChemoSen3D's headquarters located?

ChemoSen3D's headquarters is located in Houston, TX, US.

When was ChemoSen3D's last funding round?

ChemoSen3D's most recent funding round was for $165k (USD) in February 2021.

How much has ChemoSen3D raised to-date?

As of Feb 24, 2021, ChemoSen3D has raised a total of $165k (USD).

How many employees does ChemoSen3D have?

ChemoSen3D has 3 employees as of Feb 5, 2024.

ChemoSen3D - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • 3D Bioprinting
  • Biotech
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Clinical Assays
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified